Fairness opinions › Segments
Home-Based Services fairness opinions
8 public-company healthcare transactions in Home-Based Services, 2010-2026, each with the banker's fairness opinion from the SEC filing: the DCF discount rate and terminal assumptions, the selected companies and precedent transactions, and the deal terms.
Valuation benchmarks
EV / LTM EBITDA
9.7x / 12.2x / 15.4x
Q1 / median / Q3 · n=8
EV / LTM revenue
1.05x / 1.29x / 2.08x
Q1 / median / Q3 · n=8
DCF discount rate (midpoint)
9.0% / 10.0% / 11.0%
Q1 / median / Q3 · n=8
Home-Based Services transactions with a fairness opinion, 2010-2026. Multiples are enterprise value over the last-twelve-months figure disclosed in the filing; the discount rate is the midpoint of the range the banker used in its DCF.
Bankers most often engaged in Home-Based Services
Guggenheim Securities (3) · Jefferies (3) · Leerink Partners (1) · Barclays (1) · J.P. Morgan (1) · Goldman Sachs (1)
All Home-Based Services transactions
| Announced | Target | Acquirer | EV | EV/EBITDA | EV/Rev | DCF rate | Fairness opinion |
|---|---|---|---|---|---|---|---|
| 2026-02-23 | Enhabit | Kinderhook Industries | $1.1B | 10.0x | 1.01x | 11.5%–14.5% | |
| 2023-06-26 | Amedisys | UnitedHealth Group | $3.6B | 15.2x | 1.59x | 8.3%–10.5% | Guggenheim Securities |
| 2022-03-29 | LHC Group | UnitedHealth Group | $6.1B | 20.8x | 2.26x | 8.5%–9.5% | Leerink Partners, Jefferies |
| 2017-11-16 | Almost Family | LHC Group | $933M | 14.3x | 1.16x | 8.5%–10.0% | Jefferies, Guggenheim Securities |
| 2017-11-16 | LHC Group | Almost Family | $1.3B | 15.5x | 1.25x | 8.5%–10.0% | Jefferies, Guggenheim Securities |
| 2014-10-09 | Gentiva Health Services | Kindred Healthcare Services | $1.8B | 9.7x | 0.92x | 9.5%–11.5% | Barclays |
| 2012-07-02 | Lincare | Linde AG | $4.6B | 9.1x | 2.25x | 9.0%–10.0% | J.P. Morgan |
| 2010-05-24 | Odyssey Healthcare | Gentiva Health Services | $939M | 9.8x | 1.33x | 9.5%–11.0% | Goldman Sachs |
3,000+ healthcare deal-level valuation multiples
The Valuation database includes financial details for more than 3,000 healthcare M&A transactions, private and public, with deal-level multiples, categorized by segment, type, and year.